Marinus Pharmaceuticals, a company based in Radnor that focuses on therapies for seizures, is laying off nearly half of its workforce after disappointing results from a clinical trial. On Tuesday, the ...

Ganaxolone — approved by the FDA two years ago to reduce seizures in CDKL5 deficiency disorder — appears to work by acting on a chemical in the brain that calms nerve cells. According to Marinus, it ...

What is conduct disorder in children? Conduct disorder is a type of behavior disorder. It’s when a child has antisocial behavior. He or she may disregard basic social standards and rules. He or she ...

As it stands, Ztalmy is approved in an oral suspension formulation for patients with seizures associated with CDKL5 deficiency disorder (CDD) following its FDA nod in 2022. Since the approval ...

There are several different types of personality disorders, broadly categorized into cluster A, B, and C disorders. Examples include paranoid, antisocial, and dependent personality disorders.

What Is Bipolar I Disorder? Bipolar I disorder (pronounced "bipolar one" and also known as manic-depressive disorder or manic depression) is a form of mental illness. A person affected by bipolar ...

tuberous sclerosis complex (TSC), and CDKL5 deficiency disorder (CDD). A phase 3 trial in Dravet's, called DEEp SEA, started last month. Earlier this year, Longboard reported encouraging results ...

Hallucinogen Persisting Perception Disorder, as defined by the DSM-5, is specifically caused by hallucinogenic drugs, primarily but not exclusively by LSD (lysergic acid diethylamide).The disorder ...

is a pharmaceutical company focused on developing innovative treatments for seizure disorders, with a key product, ZTALMY (ganaxolone), an FDA-approved oral suspension for CDKL5 deficiency disorder.